IMRIC is on the move, raising awareness and working towards biomedical breakthroughs across Canada and Israel. Keep up with all of the latest IMRIC news and events here.

Groundbreaking Immune Approach Targets Humans Instead Of Bacteria


Scientists show for the first time how bacterial superantigen toxins work, and how short peptides can block them and save lives.

Hebrew University Finds New Immunity Approach

Prof. Raymond Kaempfer and colleagues have produced what is described as “landmark” research paper.

IMRIC’S Yuval Dor One Of Four Recipients Of Merck $1 Million Grant For Multiple Sclerosis Innovation

Merck, a leading science and technology company, announced recipients of the fourth annual Grant for Multiple Sclerosis Innovation (GMSI) during a symposium at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in London. This year, 260 proposals from 45 countries were submitted, representing innovative research projects taking place across the globe. Four research teams from the United Kingdom, Spain, Canada, Israel, Germany and Qatar were selected to share in the €1 million grant to support their research.